Significant increase in volume has been observed in Sun Pharma Advanced Research Company Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Sun Pharma Advanced Research Company Limited has submitted their response.
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The NSE flagged a significant spike in trading volume in SPARC shares and sought a clarification from the company on March 25, 2026. SPARC responded by stating that it is in full compliance with SEBI's Regulation 30 disclosure norms and has made all required disclosures to the exchanges. The company also confirmed it is not aware of any material information that should have been disclosed but hasn't been. Essentially, SPARC has no explanation for the unusual volume beyond saying nothing new is pending.
This is a neutral, procedural clarification with no new fundamental information for shareholders. The lack of any undisclosed catalyst means the volume spike was likely driven by market speculation or external factors rather than company-specific news, leaving the trading activity unexplained.